- Male or female subjects between 18-65 years of age, inclusive, at time of informed
- Must have moderate to severe active non-segmental vitiligo.
- History of human immunodeficiency virus (HIV) or positive HIV serology at screening,
- Infected with hepatitis B or hepatitis C viruses.
- Have evidence of active or latent or inadequately treated infection with Mycobacterium